Mark J. Pettenati

8.1k total citations · 1 hit paper
148 papers, 5.1k citations indexed

About

Mark J. Pettenati is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Mark J. Pettenati has authored 148 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Molecular Biology, 50 papers in Hematology and 36 papers in Genetics. Recurrent topics in Mark J. Pettenati's work include Acute Myeloid Leukemia Research (43 papers), Chronic Myeloid Leukemia Treatments (19 papers) and Acute Lymphoblastic Leukemia research (19 papers). Mark J. Pettenati is often cited by papers focused on Acute Myeloid Leukemia Research (43 papers), Chronic Myeloid Leukemia Treatments (19 papers) and Acute Lymphoblastic Leukemia research (19 papers). Mark J. Pettenati collaborates with scholars based in United States, United Kingdom and France. Mark J. Pettenati's co-authors include Andrew J. Carroll, Clara D. Bloomfield, Robert J. Mayer, P. Nagesh Rao, Richard A. Larson, Krzysztof Mrózek, Charles A. Schiffer, Ramana Tantravahi, Frederick R. Davey and Amy S. Ruppert and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Mark J. Pettenati

145 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.

1998 508 citations Andrew J. Carroll, Mark J. Pettenati et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark J. Pettenati United States	36	2.3k	2.1k	1.1k	998	620	148	5.1k
Roland P. Kuiper Netherlands	35	1.5k 0.7×	2.6k 1.2×	1.2k 1.1×	758 0.8×	473 0.8×	123	5.4k
Yasuhide Hayashi Japan	45	2.9k 1.3×	4.1k 1.9×	1.3k 1.1×	661 0.7×	727 1.2×	226	7.1k
Eileen Bryant United States	42	3.6k 1.6×	1.3k 0.6×	1.1k 1.0×	523 0.5×	1.0k 1.6×	82	5.3k
Athena M. Cherry United States	29	770 0.3×	2.2k 1.0×	663 0.6×	1.3k 1.3×	512 0.8×	81	4.7k
Marc De Braekeleer France	40	975 0.4×	1.9k 0.9×	919 0.8×	1.7k 1.7×	634 1.0×	235	5.6k
Michelle M. LeBeau United States	24	3.8k 1.7×	2.1k 1.0×	975 0.9×	568 0.6×	1.4k 2.2×	43	5.4k
Timothy A. Graubert United States	37	2.2k 1.0×	3.2k 1.5×	568 0.5×	678 0.7×	744 1.2×	112	5.9k
Tracy Chaplin United Kingdom	35	1.1k 0.5×	2.2k 1.0×	555 0.5×	441 0.4×	687 1.1×	80	3.9k
John D. Crispino United States	52	3.2k 1.4×	5.0k 2.3×	906 0.8×	979 1.0×	1.7k 2.7×	168	8.1k
O. Margaret Garson Australia	30	1.6k 0.7×	1.1k 0.5×	928 0.8×	588 0.6×	591 1.0×	116	3.1k

Countries citing papers authored by Mark J. Pettenati

Since Specialization

Citations

This map shows the geographic impact of Mark J. Pettenati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Pettenati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Pettenati more than expected).

Fields of papers citing papers by Mark J. Pettenati

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Pettenati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Pettenati. The network helps show where Mark J. Pettenati may publish in the future.

Co-authorship network of co-authors of Mark J. Pettenati

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Pettenati. A scholar is included among the top collaborators of Mark J. Pettenati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Pettenati. Mark J. Pettenati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johnston-MacAnanny, E.B., et al.. (2011). The first case described: monozygotic twin sisters with the fragile X premutation but with a different phenotype for premature ovarian failure. Fertility and Sterility. 95(7). 2431.e13–2431.e15. 10 indexed citations

Chauvenet, Allen R., Paul L. Martin, Meenakshi Devidas, et al.. (2007). Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood. 110(4). 1105–1111. 40 indexed citations

Brownlee, Noel A., et al.. (2007). Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney.. Archives of Pathology & Laboratory Medicine. 131(3). 446–451. 31 indexed citations

Gastier‐Foster, Julie M., Andrew J. Carroll, Richard C. Harvey, et al.. (2007). Two Distinct Subsets of dic(9;12)(p12;p11.2) among Children with B-Cell Precursor Acute Lymphoblastic Leukemia (ALL): PAX5-ETV6 and ETV6-RUNX1 Rearrangements: A Report from the Children’s Oncology Group.. Blood. 110(11). 1439–1439. 3 indexed citations

Pettenati, Mark J., et al.. (2005). Primary Pleuropulmonary Synovial Sarcoma Diagnosed by Fine Needle Aspiration with Cytogenetic Confirmation. Acta Cytologica. 49(6). 673–676. 6 indexed citations

Farber, Rebecca Straus, et al.. (2005). Diagnosis of Burkitt lymphoma in pediatric patients by thoracentesis. Pediatric Blood & Cancer. 49(1). 90–92. 4 indexed citations

Cruz, Julia M., et al.. (2004). Use of Fluorescence In Situ Hybridization to Detect Minimal Residual Disease in Hematopoietic Stem Cell Assays from Peripheral Blood Stem Cells of 2 Patients with Trisomy 8 Acute Myeloid Leukemia. Stem Cells and Development. 13(1). 23–26. 2 indexed citations

Zheng, Siqun L., Josyf C. Mychaleckyj, Gregory A. Hawkins, et al.. (2003). Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 528(1-2). 45–53. 16 indexed citations

Kute, Tim, et al.. (2003). Absence of HER2 overexpression in metastatic malignant melanoma. Journal of Surgical Oncology. 84(2). 82–88. 20 indexed citations

10.

Pierce, Richard A., Tuna Mutis, Tatiana N. Golovina, et al.. (2001). The HA-2 Minor Histocompatibility Antigen Is Derived from a Diallelic Gene Encoding a Novel Human Class I Myosin Protein. The Journal of Immunology. 167(6). 3223–3230. 97 indexed citations

11.

Collins, Kim, et al.. (2000). Identification of Female Cells in Postcoital Penile Swabs Using Fluorescence In Situ Hybridization Application in Sexual Assault. Archives of Pathology & Laboratory Medicine. 124(7). 1080–1082. 1 indexed citations

12.

Gilbert, John R., Arun Kumar, Sarah E. Newey, et al.. (2000). Physical and cDNA Mapping in the <i>DBH</i> Region of Human Chromosome 9q34. Human Heredity. 50(3). 151–157. 5 indexed citations

13.

Hart, Thomas C., et al.. (1998). Genetic Linkage of Hereditary Gingival Fibromatosis to Chromosome 2p21. The American Journal of Human Genetics. 62(4). 876–883. 75 indexed citations

14.

Kilpatrick, Scott E., William G. Ward, Allen R. Chauvenet, & Mark J. Pettenati. (1998). The role of fine-needle aspiration biopsy in the initial diagnosis of pediatric bone and soft tissue tumors: an institutional experience.. PubMed. 11(10). 923–8. 46 indexed citations

15.

Shashi, Vandana, et al.. (1998). A further case of choanal atresia in the deletion (9p) syndrome. American Journal of Medical Genetics. 80(4). 440–440. 2 indexed citations

16.

Jewett, Tamison, P. Suzanne Hart, P. Nagesh Rao, & Mark J. Pettenati. (1997). A case revisited: Recent presentation of incontinentia pigmenti in association with a previously reported X;autosome translocation. American Journal of Medical Genetics. 69(1). 96–97. 4 indexed citations

17.

Buss, David H., Bayard L. Powell, Michael O’Connor, et al.. (1996). Usefulness and limitations of serum and urine lysozyme levels in the classification of acute myeloid leukemia: An analysis of 208 cases. Leukemia Research. 20(6). 467–472. 19 indexed citations

18.

Wiechmann, Allan F., Gita Akots, James A. Hammarback, et al.. (1994). Genetic and physical mapping of human recoverin: a gene expressed in retinal photoreceptors.. PubMed. 35(2). 325–31. 9 indexed citations

19.

Rothschild, Cynthia, Gita Akots, Mark J. Pettenati, et al.. (1993). A genetic map of chromosome 20q12-q13.1: multiple highly polymorphic microsatellite and RFLP markers linked to the maturity-onset diabetes of the young (MODY) locus.. PubMed. 52(1). 110–23. 26 indexed citations

20.

Jewett, Tamison, P. Nagesh Rao, Richard G. Weaver, et al.. (1993). Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) associated with interstitial deletion of band 3q22: Review and gene assignment to the interface of band 3q22.3 and 3q23. American Journal of Medical Genetics. 47(8). 1147–1150. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact